Fair Value Measurements, Assets and Liabilities, Recurring Basis |
| | Total | | | Level 1 | | | Level 2 | | | Level 3 | | December 31, 2022: | | | | | | | | | | | | | Derivative liabilities | | $ | 1,233,679 | | | $ | - | | | $ | - | | | $ | 1,233,679 | | | | | | | | | | | | | | | | | | | Total liabilities measured at fair value | | $ | 1,233,679 | | | $ | - | | | $ | - | | | $ | 1,233,679 | | | | | | | | | | | | | | | | | | | December 31, 2021: | | | | | | | | | | | | | | | | | Derivative liabilities | | $ | 5,925,214 | | | $ | - | | | $ | - | | | $ | 5,925,214 | | | | | | | | | | | | | | | | | | | Total liabilities measured at fair value | | $ | 5,925,214 | | | $ | - | | | $ | - | | | $ | 5,925,214 | |
|
Schedule of Derivative Liabilities at Fair Value |
| | Convertible Notes Payable | | | Series B Preferred Stock | | | Stock Options | | | Total | | | | | | | Derivative liabilities as of December 31, 2020 | | $ | 3,368,619 | | | $ | 4,137,413 | | | $ | 3,776,059 | | | $ | 11,282,091 | | Addition to liability for new issuances | | | 2,671,728 | | | | - | | | | 4,725,180 | | | | 7,396,908 | | Elimination of liability on conversion to common shares | | | (3,774,269 | ) | | | - | | | | - | | | | (3,774,269 | ) | Change in fair value | | | (753,742 | ) | | | (4,137,413 | ) | | | (4,088,361 | ) | | | (8,979,516 | ) | | | | | | | | | | | | | | | | | | Derivative liabilities as of December 31, 2021 | | | 1,512,336 | | | | - | | | | 4,412,878 | | | | 5,925,214 | | Addition to liabilities for new issuances | | | 135,012 | | | | - | | | | 545,462 | | | | 680,474 | | Elimination of liabilities in debt conversions | | | (263,780 | ) | | | - | | | | - | | | | (263,780 | ) | Change in fair value | | | (643,411 | ) | | | - | | | | (4,464,818 | ) | | | (5,108,229 | ) | | | | | | | | | | | | | | | | | | Derivative liabilities as of December 31, 2022 | | $ | 740,157 | | | $ | - | | | $ | 493,522 | | | $ | 1,233,679 | |
|
Schedule of weighted average number of common shares outstanding |
| | Years Ended December 31, | | | | 2022 | | | 2021 | | | | | | | | | Basic weighted average number of shares | | | 433,143,911 | | | | 195,725,543 | | Dilutive effect of: | | | | | | | | | Series B preferred stock | | | 949,400,000 | | | | - | | Series E preferred stock | | | 2,706,666,667 | | | | - | | Convertible notes payable | | | 247,997,718 | | | | - | | | | | | | | | | | Diluted weighted average number of shares | | | 4,337,208,296 | | | | 195,725,543 | |
|